Filing Details
- Accession Number:
- 0000899243-21-024331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-16 21:20:07
- Reporting Period:
- 2021-06-14
- Accepted Time:
- 2021-06-16 21:20:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1735803 | Apria Inc. | APR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1343206 | P L V Partners Capital Blackstone | C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1368608 | L.l.c. V Bma | C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1368609 | L.l.c. V Associates Management Blackstone | C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1404073 | L.p. Iii Holdings Blackstone | C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1478809 | L.p. Gp Iii Holdings Blackstone | C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1478815 | L.l.c. Management Gp Iii Holdings Blackstone | C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1844887 | Bp Healthcare Holdings Llc | C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1844888 | Apria Holdings Llc | C/O The Blackstone Group Inc., 345 Park Avenue New York NY 10154 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-06-14 | 5,175,000 | $25.38 | 19,037,042 | No | 4 | S | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnotes |
Footnotes
- This amount represents the $27.00 public offering price per share of common stock of the Issuer, less the underwriting discount of $1.62 per share.
- Reflects shares held directly by Apria Holdings LLC. The controlling member of Apria Holdings LLC is BP Healthcare Holdings LLC. The controlling member of BP Healthcare Holdings LLC is Blackstone Capital Partners V L.P. The general partner of Blackstone Capital Partners V L.P. is Blackstone Management Associates V L.L.C. The sole member of Blackstone Management Associates V L.L.C. is BMA V L.L.C. The managing member of BMA V L.L.C. is Blackstone Holdings III L.P. The general partner of Blackstone Holdings III L.P. is Blackstone Holdings III GP L.P. The general partner of Blackstone Holdings III GP L.P. is Blackstone Holdings III GP Management L.L.C.
- The sole member of Blackstone Holdings III GP Management L.L.C. is The Blackstone Group Inc. The sole holder of the Series II preferred stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
- Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 4.
- Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
- Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.